Drug Usage Clinical Trial
Official title:
Optimal Dose of Dexmedetomidine for Laryngeal Mask Airway Insertion During Propofol Induction
Verified date | April 2014 |
Source | Ajou University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | Korea: Institutional Review Board |
Study type | Interventional |
The investigators attempted to determine the optimal dose of dexmedetomidine required for the successful insertion of LMA during propofol induction without a neuromuscular blocking agent.
Status | Completed |
Enrollment | 22 |
Est. completion date | August 2013 |
Est. primary completion date | August 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - ASA I-II patients undergoing general anesthesia for short elective surgery (<1 hr) Exclusion Criteria: - G-E reflux - obesity (BMI>30) - anticipated difficult airway |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Ajou University School of Medicine | Suwon |
Lead Sponsor | Collaborator |
---|---|
Ajou University School of Medicine |
Korea, Republic of,
Uzümcügil F, Canbay O, Celebi N, Karagoz AH, Ozgen S. Comparison of dexmedetomidine-propofol vs. fentanyl-propofol for laryngeal mask insertion. Eur J Anaesthesiol. 2008 Aug;25(8):675-80. doi: 10.1017/S0265021508004213. Epub 2008 Apr 10. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | successful insertion of LMA | the response of patients to the insertion of LMA (classified as either 'movement' or 'no movement') during infusion of dexmedetomidine and propofol. | from baseline to 2 min after insertion of LMA (participants will be followed for the duration of anesthetic induction, an expected average of 10 min). | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06020391 -
Cooperation for Better Treatment of Polypharmacy in the Community
|
N/A | |
Completed |
NCT02490345 -
Gabapentin as Adjunctive Treatment for Postoperative Pain Control
|
Phase 1 | |
Completed |
NCT01931683 -
Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)
|
Phase 4 | |
Withdrawn |
NCT03938077 -
A Community-University Approach to Preventing HIV
|
N/A | |
Completed |
NCT02973724 -
EC95 of Remifentanil for Preventing Cough
|
N/A | |
Completed |
NCT01152970 -
F.Y.I.: Flint Youth Injury Study
|
N/A | |
Completed |
NCT03330782 -
Remifentanil for Preventing Propofol Injection Pain in Elderly Patients
|
Phase 4 | |
Completed |
NCT01489683 -
Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine
|
N/A | |
Completed |
NCT03368456 -
Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention
|
N/A | |
Completed |
NCT02379455 -
Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Study
|
N/A | |
Completed |
NCT01963130 -
Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study
|
N/A | |
Recruiting |
NCT01496105 -
Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion
|
Phase 4 | |
Completed |
NCT02334046 -
Remifentanil for Smooth Emergence in Elderly Patients
|
Phase 4 | |
Completed |
NCT00876941 -
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
|
Phase 3 |